查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585791

近距离放射治疗治疗计划系统市场：按组件、技术和应用划分 - 2025-2030 年全球预测

Brachytherapy Treatment Planning System Market by Component (Auto-Contouring Software, DICOM-RT Software, Multi-Modality Software), Technology (3D Image Reconstruction, Image Registration, In-Room Imaging), Applications - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

近距离放射治疗治疗计划系统市场价值 2023 年为 8.0763 亿美元，预计到 2024 年将达到 9.0539 亿美元，复合年增长率为 12.50%，到 2030 年将达到 18.4215 亿美元。

近距离放射治疗计划系统 (BTPS) 市场专注于规划和实施近距离放射治疗（放射治疗的一种形式）所需的软体和技术解决方案。对 BTPS 的需求源自于需要精确、局部进行放射治疗，最大限度地减少对周围组织的损伤并提高治疗效果。在医疗保健领域，这些系统应用于前列腺癌、子宫颈癌、乳癌和皮肤癌等癌症，有助于医疗保健专业人员确定辐射种子和施放器的最佳位置和剂量。最终用途主要是医院、癌症治疗中心和放射治疗诊所。关键的成长要素包括癌症盛行率的增加、影像技术的进步、人工智慧在治疗计划中的整合以及对微创治疗方法的需求不断增加。开发人工智慧主导的软体解决方案的机会比比皆是，这些解决方案可以提高准确性、减少规划时间并提高患者吞吐量。公司还可以探索与学术机构的合作伙伴关係，以推动个人化医疗领域以研究为重点的创新。然而，市场面临初始成本高、对熟练操作员的需求以及监管复杂性等挑战。此外，发展中地区的认知度低和采用率低也是成长的障碍。此外，确保资料安全并整合各种系统以综合利用资料在技术上也具有挑战性。完美的创新领域包括用于改善临床医生互动的使用者介面增强、用于个人化治疗计划的基因组资料整合以及用于即时协作开发的云端基础的解决方案等。由于严格的监管、创新主导的竞争和持续的併购，市场情况不断变化。平衡采用最尖端科技和成本控制对于永续业务成长和利用新机会至关重要。

主要市场统计
基准年[2023] 80763万美元
预测年份 [2024] 90539万美元
预测年份 [2030] 1,842.15 百万美元
复合年增长率（%） 12.50%

市场动态：快速发展的近距离放射治疗治疗计划系统市场的关键市场洞察

近距离放射治疗治疗计划系统市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球癌症盛行率和癌症相关死亡率不断上升
    • 对准确和精确的癌症诊断的需求不断增长
    • 在癌症治疗解决方案中更多地采用放射线治疗
  • 市场限制因素
    • 系统整合高成本
  • 市场机会
    • 完善报销政策
    • 投资研发并改善近距离放射治疗
  • 市场挑战
    • 放射科缺乏熟练的医护人员

波特五力：驾驭近距离放射治疗计画系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解近距离放射治疗计画系统市场的外部影响

外部宏观环境因素在塑造近距离放射治疗计画系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解近距离放射治疗计画系统市场的竞争格局

对近距离放射治疗计划系统市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵近距离放射治疗计划系统市场供应商的绩效评估

FPNV 定位矩阵是评估近距离放射治疗计画系统市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製近距离放射治疗计划系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，近距离放射治疗计划系统市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球癌症发生率和癌症相关死亡率正在上升
      • 对准确和精确的癌症诊断的需求不断增长
      • 在癌症治疗解决方案中越来越多地采用放射线治疗
    • 抑制因素
      • 系统整合高成本
    • 机会
      • 完善报销政策
      • 投资研发并改善近距离放射治疗
    • 任务
      • 缺乏熟练的放射科医护人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章近距离放射治疗计画系统市场：依组成部分

  • 自动轮廓绘製软体
  • DICOM-RT 软体
  • 多重模式软体
  • PET/CT 转换软体

第七章近距离放射治疗计画系统市场：依技术分类

  • 3D影像重建
  • 影像配准
  • 室内影像

第八章近距离放射治疗计画系统市场：依应用分类

  • 乳癌
  • 妇科癌症
  • 摄护腺癌

第九章北美和南美近距离放射治疗计划系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区近距离放射治疗计画系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的近距离放射治疗计划系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Accuray Incorporated
  • Adaptiiv Medical Technologies Inc.
  • C4 Imaging, LLC
  • Concure Oncology, Inc
  • Eckert & Ziegler Radiopharma GmbH
  • Elekta AB
  • GE HealthCare Technologies Inc.
  • Inomed Medizintechnik GmbH
  • IsoAid
  • Koninklijke Philips NV
  • Medical Targeting Technologies GmbH
  • MIM Software Inc.
  • Perspective Therapeutics
  • Prowess Inc.
  • RaySearch Laboratories AB
  • Seedos Ltd.
  • Shinva Medical Instrument Co., Ltd.
  • Siemens Healthineers AG
  • Standard Imaging, Inc.
  • Theragenics Corporation
Product Code: MRR-742BD517C026

The Brachytherapy Treatment Planning System Market was valued at USD 807.63 million in 2023, expected to reach USD 905.39 million in 2024, and is projected to grow at a CAGR of 12.50%, to USD 1,842.15 million by 2030.

The brachytherapy treatment planning system (BTPS) market focuses on software and technological solutions necessary for planning and delivering brachytherapy, a form of radiotherapy where a source of radiation is placed inside or next to the area requiring treatment. The necessity for BTPS arises from the need for precise and localized radiation delivery, minimizing damage to surrounding tissues and enhancing treatment efficacy. Clinically, these systems are applied in managing cancers such as prostate, cervical, breast, and skin cancer, where they aid healthcare providers in determining optimal placement and dosage for radiation seeds or applicators. End-use is predominantly in hospitals, cancer treatment centers, and specialized radiotherapy clinics. Key growth factors include the increasing prevalence of cancer, advancements in imaging technologies, integration of artificial intelligence in treatment planning, and rising demand for minimally invasive treatment methods. Opportunities abound in developing AI-driven software solutions that enhance precision and reduce planning time, thus improving patient throughput. Companies could also explore partnerships with academic institutions to drive research-focused innovations in personalized medicine. However, the market faces challenges like high initial costs, the need for skilled operators, and regulatory complexities. Limited awareness and adoption rates in developing regions also pose growth hurdles. Moreover, ensuring data security and integrating various systems for cohesive data use can be technologically challenging. The best areas for innovation include enhancing user interfaces to improve clinician interactions, incorporating genomic data for personalized treatment plans, and developing cloud-based solutions for real-time collaborations. In terms of market nature, it's heavily regulated, innovation-driven, and competitive with ongoing mergers and acquisitions contributing to a continually evolving landscape. Balancing cutting-edge technology implementation with cost management will be vital for sustained business growth and capitalizing on emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 807.63 million
Estimated Year [2024] USD 905.39 million
Forecast Year [2030] USD 1,842.15 million
CAGR (%) 12.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brachytherapy Treatment Planning System Market

The Brachytherapy Treatment Planning System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cancer and cancer-related mortality globally
    • Growing demand for accurate and precise diagnosis of cancer
    • Increasing adoption of radiation therapy in cancer care solutions
  • Market Restraints
    • High cost associated with system integration
  • Market Opportunities
    • Improvement in reimbursement policies
    • Investments in R&D and improvements in brachytherapy treatment
  • Market Challenges
    • Shortage of skilled healthcare personnel in the radiology sector

Porter's Five Forces: A Strategic Tool for Navigating the Brachytherapy Treatment Planning System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brachytherapy Treatment Planning System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brachytherapy Treatment Planning System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brachytherapy Treatment Planning System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brachytherapy Treatment Planning System Market

A detailed market share analysis in the Brachytherapy Treatment Planning System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brachytherapy Treatment Planning System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brachytherapy Treatment Planning System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brachytherapy Treatment Planning System Market

A strategic analysis of the Brachytherapy Treatment Planning System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Treatment Planning System Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Adaptiiv Medical Technologies Inc., C4 Imaging, LLC, Concure Oncology, Inc, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GE HealthCare Technologies Inc., Inomed Medizintechnik GmbH, IsoAid, Koninklijke Philips N.V., Medical Targeting Technologies GmbH, MIM Software Inc., Perspective Therapeutics, Prowess Inc., RaySearch Laboratories AB, Seedos Ltd., Shinva Medical Instrument Co., Ltd., Siemens Healthineers AG, Standard Imaging, Inc., and Theragenics Corporation.

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Treatment Planning System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Auto-Contouring Software, DICOM-RT Software, Multi-Modality Software, and PET/CT Deformable Software.
  • Based on Technology, market is studied across 3D Image Reconstruction, Image Registration, and In-Room Imaging.
  • Based on Applications, market is studied across Breast Cancer, Gynecologic Cancers, and Prostate Cancer.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer and cancer-related mortality globally
      • 5.1.1.2. Growing demand for accurate and precise diagnosis of cancer
      • 5.1.1.3. Increasing adoption of radiation therapy in cancer care solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with system integration
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvement in reimbursement policies
      • 5.1.3.2. Investments in R&D and improvements in brachytherapy treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled healthcare personnel in the radiology sector
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brachytherapy Treatment Planning System Market, by Component

  • 6.1. Introduction
  • 6.2. Auto-Contouring Software
  • 6.3. DICOM-RT Software
  • 6.4. Multi-Modality Software
  • 6.5. PET/CT Deformable Software

7. Brachytherapy Treatment Planning System Market, by Technology

  • 7.1. Introduction
  • 7.2. 3D Image Reconstruction
  • 7.3. Image Registration
  • 7.4. In-Room Imaging

8. Brachytherapy Treatment Planning System Market, by Applications

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Gynecologic Cancers
  • 8.4. Prostate Cancer

9. Americas Brachytherapy Treatment Planning System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brachytherapy Treatment Planning System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brachytherapy Treatment Planning System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Accuray Incorporated
  • 2. Adaptiiv Medical Technologies Inc.
  • 3. C4 Imaging, LLC
  • 4. Concure Oncology, Inc
  • 5. Eckert & Ziegler Radiopharma GmbH
  • 6. Elekta AB
  • 7. GE HealthCare Technologies Inc.
  • 8. Inomed Medizintechnik GmbH
  • 9. IsoAid
  • 10. Koninklijke Philips N.V.
  • 11. Medical Targeting Technologies GmbH
  • 12. MIM Software Inc.
  • 13. Perspective Therapeutics
  • 14. Prowess Inc.
  • 15. RaySearch Laboratories AB
  • 16. Seedos Ltd.
  • 17. Shinva Medical Instrument Co., Ltd.
  • 18. Siemens Healthineers AG
  • 19. Standard Imaging, Inc.
  • 20. Theragenics Corporation

LIST OF FIGURES

  • FIGURE 1. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY AUTO-CONTOURING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY DICOM-RT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY MULTI-MODALITY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PET/CT DEFORMABLE SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY 3D IMAGE RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY IMAGE REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY IN-ROOM IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY GYNECOLOGIC CANCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. BRACHYTHERAPY TREATMENT PLANNING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023